Bedrijfsoverzicht
Community Health Systems, Inc. is a prominent entity within the healthcare sector, specifically operating within the medical care facilities industry by owning, leasing, and managing general acute care hospitals across the United States. The organization provides a comprehensive spectrum of clinical services, including emergency room care, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic imaging, psychiatric treatment, and rehabilitation services to its patient base. This large-scale operation employs approximately 44,000 individuals, reflecting a substantial footprint in the regional healthcare delivery system. With a market capitalization of $443.93 million and annual revenue reaching $12.49 billion, the company holds a significant position in its sector. These valuation and revenue figures indicate that while the firm commands a considerable operational scale, its market capitalization suggests a current market valuation that is relatively modest compared to its total revenue generation, which often occurs in capital-intensive industries where asset-heavy structures can influence equity market perceptions.
Financiële gezondheid
The company reported total revenue of $12.49 billion over the trailing twelve months, generating net income of $509.00 million and an EBITDA of $1.45 billion. The substantial gap between the $12.49 billion in revenue and the $509.00 million in net income reveals a cost structure where operating expenses, including the wages of 44,000 employees and facility maintenance, consume a significant portion of gross receipts before arriving at the bottom line. Free cash flow stands at $395.25 million, which indicates that the company retains sufficient liquidity after capital expenditures to potentially fund operational needs or strategic initiatives without relying solely on external financing. The company maintains a cash balance of $260.00 million against total debt of $11.04 billion, highlighting a highly leveraged balance sheet where liabilities significantly exceed liquid assets. Although the debt-to-equity ratio is listed as N/A in the available data, the sheer magnitude of debt relative to cash suggests a conservative approach to liquidity management rather than aggressive leverage expansion. The current ratio of 1.47 demonstrates that the company possesses 1.47 units of current assets for every unit of current liabilities, indicating a comfortable position regarding short-term liquidity and the ability to meet immediate financial obligations. Return on equity is listed as N/A, while return on assets stands at 5.0%, a metric that provides insight into how effectively management utilizes the company's asset base to generate earnings relative to the total investment in assets.
Waarderingsbeoordeling
The trailing twelve-month P/E ratio is recorded at 0.84, whereas the forward P/E ratio is listed as -370.59. The stark difference between these two figures, particularly the negative forward P/E, implies that expected future earnings trajectory currently cannot be valued on a multiple of projected earnings, likely due to anticipated losses or negative earnings estimates in the upcoming period. The price-to-book ratio is -0.30, which indicates that the market values the company's equity at a negative multiple of its book value, suggesting that the market perceives the company's assets as potentially overvalued on the balance sheet or that liabilities outweigh tangible equity. The price-to-sales ratio is 0.04, and the EV/EBITDA stands at 8.13; these alternative valuation metrics suggest that investors are pricing the company primarily on its sales revenue rather than earnings power, given the near-zero P/S multiple. The stock has traded between a 52-week high of $4.47 and a 52-week low of $2.26, placing the current trading price at a level that fluctuates significantly within this range depending on market conditions. With a beta of 1.97, the stock exhibits price volatility that is nearly double that of the broader market, indicating that price movements are highly sensitive to market swings and sector-specific risks.
Growth & Income
Revenue growth year-over-year is -4.9%, while earnings growth year-over-year is listed as N/A. The contraction in revenue suggests that the company is currently operating in a challenging environment or facing headwinds that have reduced its top line, and the absence of positive earnings growth data further complicates the picture of expansion. Since the dividend yield is N/A and the payout ratio is 0.0%, the company does not distribute dividends to shareholders, meaning it retains all earnings for reinvestment into growth initiatives, debt reduction, or operational improvements rather than paying out cash to investors. This strategy of reinvesting earnings rather than paying dividends is common among highly leveraged or capital-intensive firms that prioritize strengthening their balance sheet or funding expansion over shareholder returns. The overall growth and income profile for Community Health Systems, Inc. is characterized by a decline in recent revenue and a lack of dividend income, reflecting a period of consolidation or adjustment within the competitive medical care facilities landscape.